ELEVANCE HEALTH INC (ELV) Institutional Ownership Changes & 13F Activity

ELEVANCE HEALTH INC (ELV) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include First Eagle U.S. Value, Sequoia Financial Advisors, Brave Warrior Advisors, Vulcan Value Partners, and Eagle Capital Management.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q2 2023Sound Shore ManagementSell-7,750117,387$52,153,871
Q2 2023Yacktman Asset ManagementBuy1,580388,751$172,718,182
Q2 2023Hancock Classic ValueBuy965192,828$85,671,552
Q2 2023Sequoia Financial AdvisorsBuy1144,621$2,052,996
Q1 2023Viking Global InvestorsBuy282,3802,154,556$990,686,394
Q1 2023Brave Warrior AdvisorsBuy212,3531,084,768$498,787,174
Q1 2023Renaissance Technologies LLCSell-129,900172,173$79,167
Q1 2023Vulcan Value PartnersBuy92,403406,001$187,131
Q1 2023Eagle Capital ManagementSell-72,917799,793$367,752,819
Q1 2023Sequoia FundSell-19,399807,124$371,123,687
Q1 2023First Eagle U.S. ValueBuy5,1191,795,620$825,644,032
Q1 2023Lountzis Asset ManagementBuy755755$347
Q1 2023Yacktman Asset ManagementBuy471387,171$178,025,098
Q1 2023Hancock Classic ValueBuy163191,863$88,220,526
Q1 2023Sequoia Financial AdvisorsBuy1464,507$2,072,283
Q4 2022Viking Global InvestorsSell-464,6651,872,176$960,370,123
Q4 2022Eagle Capital ManagementSell-434,173872,710$447,674,049
Q4 2022Brave Warrior AdvisorsSell-317,456872,415$447,522,723
Q4 2022Sequoia FundSell-161,334826,523$423,981,503
Q4 2022Vulcan Value PartnersSell-77,455313,598$160,626
Q4 2022First Eagle U.S. ValueSell-49,4291,790,501$918,473,298
Q4 2022Renaissance Technologies LLCBuy3,200302,073$154,954
Q4 2022Sequoia Financial AdvisorsBuy1,3114,361$2,237,067
Q4 2022Yacktman Asset ManagementBuy1,168386,700$198,365,499
Q4 2022Hancock Classic ValueSell-292191,700$98,336,349
Q3 2022Viking Global InvestorsBuy872,3562,336,841$1,061,487
Q3 2022Vulcan Value PartnersSell-777,825391,053$177,632
Q3 2022Renaissance Technologies LLCBuy239,200298,873$135,760
Q3 2022First Eagle U.S. ValueSell-171,0701,839,930$835,770
Q3 2022Eagle Capital ManagementSell-33,3601,306,883$593,639

Frequently asked questions about ELV activity

  • Which institutional owners are buying ELV?

    Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ELV activity?

    "Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ELV increasing?

    Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related ELV insights